Cargando…
Exerting the Appropriate Application of Methylprednisolone in Acute Spinal Cord Injury Based on Time Course Transcriptomics Analysis
Methylprednisolone (MP) is an anti-inflammatory drug approved for the treatment of acute spinal cord injuries (SCIs). However, MP administration for SCIs has become a controversial issue while the molecular effects of MP remain unexplored to date. Therefore, delineating the benefits and side effects...
Autores principales: | Yang, Liang-Yo, Tsai, Meng-Yu, Juan, Shu-Hui, Chang, Shwu-Fen, Yu, Chang-Tze Ricky, Lin, Jung-Chun, Johnson, Kory R., Lim, Hendrick Gao-Min, Fann, Yang C., Lee, Yuan-Chii Gladys |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657964/ https://www.ncbi.nlm.nih.gov/pubmed/34884829 http://dx.doi.org/10.3390/ijms222313024 |
Ejemplares similares
-
Robust Mutation Profiling of SARS-CoV-2 Variants from Multiple Raw Illumina Sequencing Data with Cloud Workflow
por: Lim, Hendrick Gao-Min, et al.
Publicado: (2022) -
Methylprednisolone exerts neuroprotective effects by regulating autophagy and apoptosis
por: Gao, Wei, et al.
Publicado: (2016) -
Patients with Spinal Cord Injuries Favor Administration of Methylprednisolone
por: Bowers, Christian A., et al.
Publicado: (2016) -
Methylprednisolone for acute spinal cord injury: an increasingly philosophical debate
por: Bowers, Christian A., et al.
Publicado: (2016) -
Melatonin Synergizes With Methylprednisolone to Ameliorate Acute Spinal Cord Injury
por: Bi, Jiaqi, et al.
Publicado: (2022)